We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: April 11, 2011
Last Update Posted: July 25, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 23, 2011
  Primary Completion Date: May 23, 2011 (Final data collection date for primary outcome measure)